Related Experiment Video
Updated: May 10, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Palliative care in Parkinson's disease
1The Movement Disorders Centre, The Edmond J Safra Program in Parkinson's Disease, University of Toronto, Toronto, Canada. miyasaki@uhnresearch.ca
Current Neurology and Neuroscience Reports
|June 14, 2013
Summary
Palliative care offers a new approach for Parkinson disease (PD) patients facing increased mortality risk. This holistic, interdisciplinary care model addresses advanced symptoms and improves end-of-life support for patients and caregivers.
Area of Science:
- Neurodegenerative disease research
- Palliative and end-of-life care
- Movement disorder management
Background:
- Parkinson disease (PD) significantly increases mortality risk, often due to aspiration pneumonia, despite advances in symptom management.
- Palliative care is an emerging concept in neurodegenerative disease, focusing on holistic symptom management.
- Effective management of both motor and non-motor symptoms is crucial throughout the PD progression.
Purpose of the Study:
- To introduce palliative care as a vital component of advanced Parkinson disease management.
- To discuss key considerations for implementing palliative care in PD, including timing, communication, and assessment.
- To highlight the role of the Edmonton Symptom Assessment Scale-PD in guiding interventions.
Main Methods:
- Literature review and synthesis of current evidence on palliative care in PD.
- Discussion of best practices for integrating palliative care principles into neurodegenerative care.
- Exploration of assessment tools for symptom management in advanced PD.
Main Results:
- Palliative care provides an interdisciplinary and holistic framework for managing complex symptoms in PD.
- The Edmonton Symptom Assessment Scale-PD aids in identifying and tracking symptom severity and intervention effectiveness.
- Strategic implementation of palliative care addresses the needs of PD patients from advanced stages through end-of-life.
Conclusions:
- Integrating palliative care principles is essential for neurologists to comprehensively manage Parkinson disease patients.
- Early consideration and communication regarding palliative care can significantly improve patient and caregiver outcomes.
- Palliative care ensures that the holistic needs of individuals with advanced PD are met, enhancing quality of life until the end of life.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:25Continuing Care
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...